Clinical

David Geldmacher, MD Answers Questions on New Alzheimer's Drug

Jul 16, 2021 at 03:21 pm by steve

On June 7th, the FDA approved Biogen's Aduhelm (aducanumab), which is the first new drug for Alzheimer's disease in 18 years. This caused some controversy among researchers, s.... Read More

Help for a Previously Untreatable Disease

Jun 09, 2021 at 11:16 am by steve

Amyloidosis is one of those conditions that tend to show up on medical board exams--intriguing, thought to be rare, and until recently, essentially untreatable. However, advan.... Read More

Dapagliflozin Approved for Prevention of CKD Progression

Jun 09, 2021 at 10:57 am by steve

Chronic kidney disease patients with protein in their urine have a higher risk of dying than the general population, and diabetes is currently the number one cause of the dise.... Read More

Brain Health Starts Early

Jun 09, 2021 at 10:56 am by steve

What's good for the heart also tends to be good for the brain. If your patients want to live a long, healthy life and still be sharp enough at 85, today is the day to get star.... Read More

The Brain After COVID-19

Jun 09, 2021 at 10:54 am by steve

COVID-19 survivors are 44 percent more likely to experience neurological and psychiatric complications within the first six months after they are infected than patients recove.... Read More